UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis Journal article
Li, Junnan, Chen, Pengchen, Wu, Qiushuang, Guo, Libin, Leong, Ka Weng, Chan, Kin Iong, Kwok, Hang Fai. A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis[J]. Cellular and Molecular Life Sciences, 2022, 79(12), 614.
Authors:  Li, Junnan;  Chen, Pengchen;  Wu, Qiushuang;  Guo, Libin;  Leong, Ka Weng; et al.
Favorite | TC[WOS]:7 TC[Scopus]:6  IF:6.2/7.7 | Submit date:2023/01/30
Antibody Therapy  Cell Death  Drug Target  Precision Oncology  Small Molecule  
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 Other
2016-01-01
Authors:  Klionsky, Daniel J.;  Abdelmohsen, Kotb;  Abe, Akihisa;  Abedin, Md Joynal;  Abeliovich, Hagai; et al.
Favorite | TC[WOS]:407 TC[Scopus]:24 | Submit date:2022/07/20
Evaluation of trade-offs between workflow escalation strategies Journal article
Yain-Whar Si, Marlon Dumas, Ka-Leong Chan. Evaluation of trade-offs between workflow escalation strategies[J]. Concurrent Engineering Research and Applications, 2014, 22(1), 77-88.
Authors:  Yain-Whar Si;  Marlon Dumas;  Ka-Leong Chan
Favorite | TC[WOS]:1 TC[Scopus]:2 | Submit date:2019/02/14
Escalation Strategy  Key Performance Indicators  Simulation  Workflow Management